In this study, we observed that: 1) ANRIL relative expression was higher in CAD patients compared to controls, it could distinguish CAD patients from controls, and it was positively associated with severity of coronary artery damage and systemic inflammation; 2) ANRIL high expression was correlated with worse OS in CAD patients. Here, CDKN2B-AS1 is linked to coronary artery disorder.